{"id":"NCT00130728","sponsor":"Genentech, Inc.","briefTitle":"A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer","officialTitle":"A Phase III, Multicenter, Placebo-Controlled, Double-Blind, Randomized Clinical Trial to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva (Erlotinib) Compared With Tarceva Alone for Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) After Failure of Standard First-Line Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-06-08","primaryCompletion":"2008-07-15","completion":"2019-12-23","firstPosted":"2005-08-16","resultsPosted":"2011-11-03","lastUpdate":"2021-01-14"},"enrollment":636,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"bevacizumab","otherNames":[]},{"type":"DRUG","name":"erlotinib HCl","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"erlotinib HCl + bevacizumab","type":"EXPERIMENTAL"},{"label":"erlotinib HCl + placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase III, multicenter, placebo-controlled, double-blind, randomized study. Approximately 650 patients will be randomized in a 1:1 ratio to one of two treatment arms.","primaryOutcome":{"measure":"Overall Survival (OS) Among All Randomized Patients","timeFrame":"From the date of randomization until the date of patient death from any cause, or the date of last contact. (Up to 3.1 years)","effectByArm":[{"arm":"Erlotinib HCl + Bevacizumab","deltaMin":9.3,"sd":null},{"arm":"Erlotinib HCl + Placebo","deltaMin":9.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.7583"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":23},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":["21621716"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":146,"n":313},"commonTop":["Rash","Diarrhoea","Fatigue","Nausea","Anorexia"]}}